 | • レポートコード：MRC2-11QY12275 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は高カルシウム血症治療のグローバル市場について調査・分析したレポートです。種類別（ビスフォスフォネート、糖質コルチコイド、カルシウム模倣薬）市場規模、用途別（軽度高カルシウム血症、中等度高カルシウム血症、重度高カルシウム血症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別高カルシウム血症治療の競争状況、市場シェア ・世界の高カルシウム血症治療市場：種類別市場規模 2015年-2020年（ビスフォスフォネート、糖質コルチコイド、カルシウム模倣薬） ・世界の高カルシウム血症治療市場：種類別市場規模予測 2021年-2026年（ビスフォスフォネート、糖質コルチコイド、カルシウム模倣薬） ・世界の高カルシウム血症治療市場：用途別市場規模 2015年-2020年（軽度高カルシウム血症、中等度高カルシウム血症、重度高カルシウム血症） ・世界の高カルシウム血症治療市場：用途別市場規模予測 2021年-2026年（軽度高カルシウム血症、中等度高カルシウム血症、重度高カルシウム血症） ・北米の高カルシウム血症治療市場分析：米国、カナダ ・ヨーロッパの高カルシウム血症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの高カルシウム血症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の高カルシウム血症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの高カルシウム血症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、Amgen、Merck、Novartis、OPKO Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hypercalcemia is a condition caused by above normal levels of calcium in the body, with serum calcium level greater than 2.6 mmol/L. It is a life threatening metabolic disorder associated with neoplastic diseases and occurs in 10% to 20% of all adults suffering from cancer; particularly lung and breast cancer, and myeloma.
The increasing instances of surgical procedures, such as hip and knee replacements, will increase the risk of hypercalcemia and drive the growth prospects for the global hypercalcemia treatment market in the upcoming years. The study also shows that the prevalence of broken bone repair surgeries, cardiovascular procedures, percutaneous coronary interventions, joint replacement surgeries, knee replacement surgeries, hip replacement surgeries, and cases of coronary artery bypass grafting will increase the chances of developing hypercalcemia post surgeries. Consequently, the demand for hypercalcemia treatment drugs will also increase during the predicted period.
Market Analysis and Insights: Global Hypercalcemia Treatment Market
The global Hypercalcemia Treatment market size is projected to reach US$ 9233.6 million by 2026, from US$ 8452.3 million in 2020, at a CAGR of 8.6%% during 2021-2026.
Global Hypercalcemia Treatment Scope and Market Size
Hypercalcemia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hypercalcemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie
Amgen
Merck
Novartis
OPKO Health
…
Market segment by Type, the product can be split into
Bisphosphonates
Glucocorticoids
Calcimimetic Agents
Market segment by Application, split into
Mild Hypercalcemia
Moderate Hypercalcemia
Severe Hypercalcemia
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hypercalcemia Treatment Revenue
1.4 Market by Type
1.4.1 Global Hypercalcemia Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Bisphosphonates
1.4.3 Glucocorticoids
1.4.4 Calcimimetic Agents
1.5 Market by Application
1.5.1 Global Hypercalcemia Treatment Market Share by Application: 2020 VS 2026
1.5.2 Mild Hypercalcemia
1.5.3 Moderate Hypercalcemia
1.5.4 Severe Hypercalcemia
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hypercalcemia Treatment Market Perspective (2015-2026)
2.2 Global Hypercalcemia Treatment Growth Trends by Regions
2.2.1 Hypercalcemia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hypercalcemia Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Hypercalcemia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hypercalcemia Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Hypercalcemia Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hypercalcemia Treatment Players by Market Size
3.1.1 Global Top Hypercalcemia Treatment Players by Revenue (2015-2020)
3.1.2 Global Hypercalcemia Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Hypercalcemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hypercalcemia Treatment Market Concentration Ratio
3.2.1 Global Hypercalcemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hypercalcemia Treatment Revenue in 2019
3.3 Hypercalcemia Treatment Key Players Head office and Area Served
3.4 Key Players Hypercalcemia Treatment Product Solution and Service
3.5 Date of Enter into Hypercalcemia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hypercalcemia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hypercalcemia Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hypercalcemia Treatment Market Size by Application (2015-2020)
5.2 Global Hypercalcemia Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hypercalcemia Treatment Market Size (2015-2020)
6.2 Hypercalcemia Treatment Key Players in North America (2019-2020)
6.3 North America Hypercalcemia Treatment Market Size by Type (2015-2020)
6.4 North America Hypercalcemia Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hypercalcemia Treatment Market Size (2015-2020)
7.2 Hypercalcemia Treatment Key Players in Europe (2019-2020)
7.3 Europe Hypercalcemia Treatment Market Size by Type (2015-2020)
7.4 Europe Hypercalcemia Treatment Market Size by Application (2015-2020)
8 China
8.1 China Hypercalcemia Treatment Market Size (2015-2020)
8.2 Hypercalcemia Treatment Key Players in China (2019-2020)
8.3 China Hypercalcemia Treatment Market Size by Type (2015-2020)
8.4 China Hypercalcemia Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hypercalcemia Treatment Market Size (2015-2020)
9.2 Hypercalcemia Treatment Key Players in Japan (2019-2020)
9.3 Japan Hypercalcemia Treatment Market Size by Type (2015-2020)
9.4 Japan Hypercalcemia Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hypercalcemia Treatment Market Size (2015-2020)
10.2 Hypercalcemia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hypercalcemia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hypercalcemia Treatment Market Size by Application (2015-2020)
11 India
11.1 India Hypercalcemia Treatment Market Size (2015-2020)
11.2 Hypercalcemia Treatment Key Players in India (2019-2020)
11.3 India Hypercalcemia Treatment Market Size by Type (2015-2020)
11.4 India Hypercalcemia Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hypercalcemia Treatment Market Size (2015-2020)
12.2 Hypercalcemia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hypercalcemia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hypercalcemia Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Hypercalcemia Treatment Introduction
13.1.4 AbbVie Revenue in Hypercalcemia Treatment Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Hypercalcemia Treatment Introduction
13.2.4 Amgen Revenue in Hypercalcemia Treatment Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Hypercalcemia Treatment Introduction
13.3.4 Merck Revenue in Hypercalcemia Treatment Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Hypercalcemia Treatment Introduction
13.4.4 Novartis Revenue in Hypercalcemia Treatment Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 OPKO Health
13.5.1 OPKO Health Company Details
13.5.2 OPKO Health Business Overview
13.5.3 OPKO Health Hypercalcemia Treatment Introduction
13.5.4 OPKO Health Revenue in Hypercalcemia Treatment Business (2015-2020)
13.5.5 OPKO Health Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hypercalcemia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hypercalcemia Treatment Revenue
Table 3. Ranking of Global Top Hypercalcemia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hypercalcemia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bisphosphonates
Table 6. Key Players of Glucocorticoids
Table 7. Key Players of Calcimimetic Agents
Table 8. Global Hypercalcemia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Hypercalcemia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Hypercalcemia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Hypercalcemia Treatment Market Share by Regions (2015-2020)
Table 12. Global Hypercalcemia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Hypercalcemia Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Hypercalcemia Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Hypercalcemia Treatment Players
Table 19. Global Hypercalcemia Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Hypercalcemia Treatment Market Share by Players (2015-2020)
Table 21. Global Top Hypercalcemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypercalcemia Treatment as of 2019)
Table 22. Global Hypercalcemia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hypercalcemia Treatment Product Solution and Service
Table 25. Date of Enter into Hypercalcemia Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hypercalcemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Hypercalcemia Treatment Market Size Share by Type (2015-2020)
Table 29. Global Hypercalcemia Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Hypercalcemia Treatment Market Size Share by Application (2015-2020)
Table 31. Global Hypercalcemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Hypercalcemia Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Hypercalcemia Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Hypercalcemia Treatment Market Share (2019-2020)
Table 35. North America Hypercalcemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Hypercalcemia Treatment Market Share by Type (2015-2020)
Table 37. North America Hypercalcemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Hypercalcemia Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Hypercalcemia Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Hypercalcemia Treatment Market Share (2019-2020)
Table 41. Europe Hypercalcemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Hypercalcemia Treatment Market Share by Type (2015-2020)
Table 43. Europe Hypercalcemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Hypercalcemia Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Hypercalcemia Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Hypercalcemia Treatment Market Share (2019-2020)
Table 47. China Hypercalcemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Hypercalcemia Treatment Market Share by Type (2015-2020)
Table 49. China Hypercalcemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Hypercalcemia Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Hypercalcemia Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Hypercalcemia Treatment Market Share (2019-2020)
Table 53. Japan Hypercalcemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Hypercalcemia Treatment Market Share by Type (2015-2020)
Table 55. Japan Hypercalcemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Hypercalcemia Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Hypercalcemia Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Hypercalcemia Treatment Market Share (2019-2020)
Table 59. Southeast Asia Hypercalcemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Hypercalcemia Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Hypercalcemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Hypercalcemia Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Hypercalcemia Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Hypercalcemia Treatment Market Share (2019-2020)
Table 65. India Hypercalcemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Hypercalcemia Treatment Market Share by Type (2015-2020)
Table 67. India Hypercalcemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Hypercalcemia Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Hypercalcemia Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Hypercalcemia Treatment Market Share (2019-2020)
Table 71. Central & South America Hypercalcemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Hypercalcemia Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Hypercalcemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Hypercalcemia Treatment Market Share by Application (2015-2020)
Table 75. AbbVie Company Details
Table 76. AbbVie Business Overview
Table 77. AbbVie Product
Table 78. AbbVie Revenue in Hypercalcemia Treatment Business (2015-2020) (Million US$)
Table 79. AbbVie Recent Development
Table 80. Amgen Company Details
Table 81. Amgen Business Overview
Table 82. Amgen Product
Table 83. Amgen Revenue in Hypercalcemia Treatment Business (2015-2020) (Million US$)
Table 84. Amgen Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Hypercalcemia Treatment Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Hypercalcemia Treatment Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. OPKO Health Company Details
Table 96. OPKO Health Business Overview
Table 97. OPKO Health Product
Table 98. OPKO Health Revenue in Hypercalcemia Treatment Business (2015-2020) (Million US$)
Table 99. OPKO Health Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypercalcemia Treatment Market Share by Type: 2020 VS 2026
Figure 2. Bisphosphonates Features
Figure 3. Glucocorticoids Features
Figure 4. Calcimimetic Agents Features
Figure 5. Global Hypercalcemia Treatment Market Share by Application: 2020 VS 2026
Figure 6. Mild Hypercalcemia Case Studies
Figure 7. Moderate Hypercalcemia Case Studies
Figure 8. Severe Hypercalcemia Case Studies
Figure 9. Hypercalcemia Treatment Report Years Considered
Figure 10. Global Hypercalcemia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Hypercalcemia Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Hypercalcemia Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Hypercalcemia Treatment Market Share by Players in 2019
Figure 15. Global Top Hypercalcemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypercalcemia Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hypercalcemia Treatment Revenue in 2019
Figure 17. North America Hypercalcemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Hypercalcemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Hypercalcemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Hypercalcemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Hypercalcemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Hypercalcemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Hypercalcemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
軽度・中等度アトピー性皮膚炎治療の世界市場（～2026年） Mild-to-moderate atopic dermatitis is a chronic inflammatory skin disease often confined to the flexural surfaces of the body and usually begins in childhood. Drug treatment can further be segmented into antihistamines, antibiotics, emollients, corticosteroids, and calcineurin inhibitors. Market Ana…- 骨・ミネラル代謝障害治療の世界市場（～2026年） Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone re…
- 多発性骨髄腫治療の世界市場（～2026年） Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to acc…
- トリプルネガティブ乳がん治療の世界市場（～2026年） Market Analysis and Insights: Global Triple-Negative Breast Cancer Treatment Market The global Triple-Negative Breast Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Triple-Negative Breast Cancer Treat…
- 萎縮性胃炎治療の世界市場（～2026年） Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity dire…